Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Cancer Research|October 1, 1981
Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycinP S Ritch, S J Occhipinti, R E Cunningham, et al.Current Eye Research|January 1, 1987
The antiherpesvirus activity and cytotoxicity of sangivamycinW J O'Brien, J L Taylor, T P O'Malley, et al.American Journal of Clinical Oncology|June 1, 1987
Continuous 5-fluorouracil infusion and pulse methotrexate/leucovorin for colorectal adenocarcinoma. A report of excessive toxicityR M Hansen, E J Quebbeman, P S Ritch, et al.Cancer|September 1, 1990
Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomasE C Borden, D A Amato, J H Edmonson, et al.Cytometry|July 1, 1983
A practical graphical method for estimating the fraction of cells in S in DNA histograms from clinical tumor samples containing aneuploid cell populationsP S Ritch, S E Shackney, W H Schuette, et al.American Journal of Hematology|June 1, 1991
Evaluation of continuous infusion low-dose 5-azacytidine in the treatment of myelodysplastic syndromesC R Chitambar, J A Libnoch, W G Matthaeus, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 1, 1996
Phase I/IB study of polyadenylic-polyuridylic acid in patients with advanced malignancies: clinical and biologic effectsP L Witt, S Zahir, P S Ritch, et al.Cancer|April 1, 1986
Treatment of intraocular lymphoma with high-dose Ara-CM A Baumann, P S Ritch, K R Hande, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1996
Hematologic and immunologic evaluation of recombinant human interleukin-6 in patients with advanced malignant disease: evidence for monocyte activationC A Keever-Taylor, P L Witt, R L Truitt, et al.Cancer Research|November 1, 1993
Phase I trial of an oral immunomodulator and interferon inducer in cancer patientsP L Witt, P S Ritch, D Reding, et al.Pageof 5